Radiotherapy for prostate cancer: how do we define success?

Area of Science:

• Oncology
• Urology
• Radiation Oncology

Background:

• External beam radiotherapy is a standard treatment for localized prostate cancer.
• Traditional success metrics include overall survival and clinical disease absence.
• Advanced assessment methods reveal higher rates of residual or recurrent disease.

Purpose of the Study:

• To critically evaluate established and novel outcome parameters for external beam radiotherapy in prostate cancer management.
• To provide a clinically relevant perspective on interpreting post-radiotherapy data for urologists.

Main Methods:

• Review of traditional outcome measures (survival, clinical exam).
• Analysis of data from post-radiotherapy biopsies.
• Evaluation of serum prostate-specific antigen (PSA) kinetics post-treatment.

Main Results:

• Post-radiotherapy biopsies and PSA monitoring detect residual/recurrent prostate cancer more sensitively than clinical assessment.
• Discrepancies between clinical assessment and objective measures are common.
• These advanced metrics offer a more precise understanding of treatment efficacy.

Conclusions:

• Post-radiotherapy biopsies and PSA monitoring are crucial for accurate assessment of treatment outcomes in localized prostate cancer.
• Integrating these objective measures enhances the clinical perspective on radiotherapy effectiveness.
• Urologists should utilize these parameters for improved patient management and follow-up.